Extracellular Vesicles (EVs), membrane vesicles released by all cells, are emerging mediators of cell-cell communication. By carrying biomolecules from tissues to biofluids, EVs have attracted attention as non-invasive sources of clinical biomarkers in liquid biopsies. Although frequently employed for content characterization of EVs, the study of bulk preparations lacks information on sub-populations and the intrinsic heterogeneity of vesicles. Importantly, these strategies also difficult the characterization of EVs from small quantities of samples. We here present a Flow Cytometry strategy that enables detailed population analysis of EVs, at the same time decreasing sample volume requirements and accelerating the overall processing time. We show its unique application for quality control of isolates of EVs by comparing the proportion of vesicular and non-vesicular particles in samples prepared by different protocols. In addition, we demonstrate its suitability for the study of populations of EVs from samples characterized by challenging small volumes. To illustrate that, we perform longitudinal non-lethal analysis of EVs in mouse plasma and in single-animal collections of murine vitreous humor. By allowing for the analysis of EVs from minimal amounts of sample, our Flow Cytometry strategy has an unexplored potential in the study of EVs in clinical samples with intrinsically limited volumes. When compared to conventional methods, it also multiplies by several times the number of different analytes that can be studied from a single collection of biofluid.
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Introduction:
Extracellular Vesicles (EVs), membrane vesicles released by all cells, are emerging players in cell-cell communication. In addition to differences in size and biogenesis mechanism, EVs are highly heterogeneous in molecular composition and biological properties. [1] [2] [3] [4] Their cargo includes proteins, lipids and nucleic acids, which can be transported both locally and to distant cellular targets through the peripheral circulation. As shown by us [5] [6] [7] [8] and others, 9 EVs can carry biomolecules from tissues to biofluids and serve as non-invasive sources of liquid biopsies for clinical biomarkers.
The study of EVs often involves the separation of vesicles of similar size (e.g. by ultrafiltration, size exclusion chromatography, nanowire-based traps and deterministic lateral displacement systems), mass and/or density (e.g. by gradient-coupled ultracentrifugation and acoustic separation systems). Once isolated, pooled EVs can be studied for their protein (e.g. by western blotting and mass spectrometry), lipid (e.g. by mass spectrometry) and nucleic acid (e.g. by PCR, DNA and RNA sequencing) content. [10] [11] [12] Despite enabling the characterization of a group of vesicles, these methods lack information on subpopulations and molecular heterogeneity of EVs at a singlevesicle level.
Technologies based on immunoaffinity capture surfaces and beads, such as ELISA and conventional flow cytometry, have enabled the analysis of populations of EVs expressing specific antigens. 2, 11 However, by capturing heterogeneous groups of EVs containing a common molecule of interest or due to resolution limitations, these methods do not allow for single-vesicle analysis of small EVs. [13] [14] [15] Nanoparticle Tracking Analysis, such as Nanosight, has been used to perform studies of single EVs. However, current protocols cannot study simultaneously single EVs co-stained with more than one dye/fluorescent-conjugated antibody, which limits the study of multiple parameters at a single EV level 16 . Other techniques, such as transmission electron microscopy, perform highly detailed analysis of the structure and antigen expression of single EVs. However, they frequently limit the number of EVs analyzed per sample, complicating the study of large number of EVs and, consequently, the accurate estimation of EVs populations of interest.
By tackling some of these issues, Flow Cytometry (FC) has emerged as a promising tool for thorough single-EV studies. However, existing protocols require EVs' isolation 1, 17-20 , volume concentration 21 or immunocapture of subsets of EVs 22 prior to staining. All these factors increase the processing time, limit the analysis of EVs to subpopulations containing biomolecules of interest and/or prevent sample analysis of small volumes and/or low numbers of EVs.
We here present a strategy that, by not requiring isolation of EVs or concentration prior to staining ( Fig.1a ), enables analysis of single EVs in both isolated and non-purified samples. We also show its application to quantitatively assess the purity of isolates of EVs prepared by different protocols. Furthermore, we demonstrate its ability to analyze populations of EVs in microvolumes of biofluids, by using it for a longitudinal population study of individual mouse plasma and of individual mouse vitreous humor collections.
Methods

Cells
The C57Bl/6 murine PAN02 cell line (also identified as Panc 02, originally induced by 3-MCA 23 ) was purchased from the DTP, DCTD Tumor Repository, NIH, and cultured in RPMI 1640 (Corning 15363561,NY, US). The medium was supplemented with 10 % Fetal Bovine Serum (FBS, Biowest S181BH-500, Nuaillé, France) and 1 % penicillin-streptomycin (Gibco 15-140-122, US), and maintained in a humid incubator with 5 % CO 2 at 37 o C. For conditioning, cells were cultured in DMEM, High Glucose, No Glutamine, No Phenol Red (Gibco 31-053-028, US) supplemented with 1 % penicillin-streptomycin and 10 % EV-depleted FBS. FBS was depleted of bovine EVs by ultracentrifugation at 100,000 g for 140 minutes. For the preparation of conditioned medium, 1x10 6 PAN02 cells were seeded per 150 mm culture dish containing 20 mL of medium, and the conditioned medium was collected after 72 hours of culture.
Tumor induction, and plasma and vitreous humor collection
All mouse work was performed in accordance with national animal experimentation guidelines (DGAV), animal protocol 0421/000/000/2018. Adult C57Bl/6 female mice (five to eight weeks old) were used for all experimental procedures. Mice were anesthetized using isoflurane 1.5-3 %. Mouse vitreous humor was collected from naïve mice using 29G syringes (BD 324892, New Jersey, US) inserted at a 45° angle into the vitreous cavity 2 mm posterior to the limbus. For tumor induction, a suspension of 1.5x10 6 PAN02 tumor cells, resuspended in 30 µL Matrigel (Corning 354230, NY, US), was injected intrahepatically with 29G syringes. Blood was collected by retroorbital bleeding via heparinized glass capillary tubes or by submandibular bleeding via blood collection lancets.
Purification and characterization of EVs
Mouse blood (3.5 mL) and supernatant fraction of conditioned medium (80 mL) were centrifuged at 500 g for 10 minutes. The collected supernatant was then centrifuged at 3,000 g for 20 minutes (these samples are from now on referred to as "non-purified" -NP -samples), followed by another centrifugation at 12,000 g for 20 minutes. After these initial steps, purification of EVs was performed in plasma by UC-I (bellow) and in conditioned medium according to one of the following protocols ( -(UC-II) 100,000 g for 140 minutes. Pellet was washed with filtered PBS and centrifuged at 100,000 g for 18 hours. The EV-containing pellet was resuspended in filtered PBS;
-(UC-III) 100,000 g for 70 minutes, followed by resuspension of the EV-containing pellet in filtered PBS;
-(UC-IV) 100,000 g for 70 minutes. Pellet was washed with PBS and again centrifuged at 100,000 g for another 70 minutes. The EV-containing pellet was resuspended in filtered PBS.
All solutions used (PBS and sucrose cushion) were sterile (0.22 µm membranefiltered). The ultracentrifugation (UC) steps were performed in refrigerated conditions (4 o C) with rotors 50.4Ti or 70Ti (Beckman-Coulter, California, US).
EVs' Flow Cytometry
Supernatant fraction of conditioned medium (100 µL), mouse plasma (1 µL in 50 µL of 5,000 U-I-/mL heparin) and vitreous humor (1 µL diluted in 20 µL of 5,000 U-I-/mL heparin) were centrifuged at 500 g for 10 minutes. The collected supernatant was then centrifuged at 3,000 g for 20 minutes. As a simple approach to normalize the input for our staining protocol, all samples were analyzed for particle concentration and size distribution by the NS300 Nanoparticle Tracking Analysis (NTA) system with red laser (638nm) (NanoSight -Malvern Panalytical, UK). Samples were pre-diluted in filtered PBS to achieve a concentration within the range for optimal NTA analysis. Video acquisitions were performed using a camera level of 16 and a threshold between 5 and 7. Five to nine videos of 30 seconds were captured per sample. Analysis of particle concentration per mL and size distribution were performed with the NTA software v3.4. Table S1 .
As internal controls across assays, before each FC experiment we used two commercially available mixes of beads (Apogee 1493 and Apogee 1517, Apogee Flow Systems, UK). Before loading, samples were diluted in filtered PBS to bring their concentration within the operational range of the equipment (maximum of 3,000 events/second). All samples were run at a flow rate of 1.5 µL/minute using a 405 nm - 
NP-40 Treatment
EVs were lysed by incubation with 2 % NP-40 (Thermo Fisher Scientific 85124, MA, USA) for 1 hour at room temperature, and then stained with CFSE and analyzed by our FC strategy, as described above.
Statistical analysis
Error 
Results
Assessment of Flow Cytometry Parameters
Silica and Polystyrene beads were used as reference particles for our EV measurements. Using our settings, it is possible to detect particles that scatter light similarly to 100 nm silica (SiO 2 ) beads ( Fig.S1a -i,ii and iii). In this ApogeeMix, SiO 2 beads have a refractive index ( ) ( =1.42-1.43) close to that of EVs ( ~1.39). 24, 25 Particle concentration and size distribution were verified by Nanoparticle Tracking Analysis ( Fig.S1a -iv). To identify event coincidence and swarming regime 26 in our experimental settings, serial dilutions of isolated EVs were performed. The working range was set in the linear region within the operational range indicated by the Apogee A60-Micro-Plus manufacturer (maximum of 3,000 events/second) ( Fig.S1b ).
Validation of the EVs staining protocol
Our FC strategy relies on the staining of vesicular particles with CFSE ( Fig.1a ), as previously described in the literature. 17, 19, 27 A subset of the experiments showed here was performed with conditioned medium, in which cells were grown in medium containing EVs-depleted FBS. To control for the presence of serum-derived vesicles in our samples, serum-free medium and medium containing 10 % of EVs-depleted FBS were stained with CFSE and analyzed using our standard settings, with flow cytometry data being acquired for similar periods of time. CFSE + events count in medium containing 10 % of EVs-depleted FBS were as low as those found in serum-free medium ( Fig. S1c) . For all subsequent analyses, quadrant thresholds were established with unstained and single-stained EVs. Vesicle-free controls containing CFSE, anti-CD9, and both CFSE and anti-CD9 are also shown. Samples were captured using equal time periods, similar to the acquisition times of corresponding samples containing EVs (Fig.S2a ). To ensure that Anti-CD9 staining was performed in optimal experimental conditions, incremental concentrations of Anti-CD9 were tested (Fig.S2b) . The working amount of Anti-CD9, was set at 0.4 µg. To certify that the observed CFSE + events were indeed vesicles, isolated EVs were pre-incubated with 2 % NP-40 for 1 hour at room temperature and analyzed using our FC strategy. A reduction of 90 % of CFSE + events was found upon detergent treatment, confirming that most of the observed CFSE + events were EVs (Fig. S2c) .
Assessment of standardized unit molecules of equivalent soluble fluorochrome (MESF) values allows for cross comparisons between different instruments and laboratories. 28, 29 In this work, MESF for PE and FITC were then used to determine the fluorescence intensity. The MESF values were measured, with the same acquisition settings applied for all the assays and using a set of Rainbow Beads containing 4 bead populations with known equivalents of FITC molecules and 4 bead populations with known equivalents of PE molecules (Fig. S3a) . After data collection, the Median Fluorescence intensity (MFI) of these peaks was converted to Relative Channel Number (#CH), and a linear regression of #CH vs log MESF values was performed ( Fig. S3b   and c) . This regression allowed for the calculation of MESF values of our experimental controls. In our experimental setting the gates for CFSE + and CD9 + were defined such that the CFSEand CD9populations displayed approximately 517 and 371 MESF, respectively. The CFSE + population was approximately 10501 MESF whereas the PE + population (CD9) was approximately 1441 MESF (Fig. S3d) .
Quantification of populations of EVs in conditioned medium
The quantification of vesicles in conditioned medium (NP) from native tumor cells by our FC strategy showed that ~40 % of particles were CFSE + (Figs. 1b and S4a) . On the other hand, samples isolated by sucrose cushion-coupled differential ultracentrifugation (UC-I), considered a high-specificity method, contained ~85 % of CFSE + vesicles. Different EVs isolation protocols by ultracentrifugation may utilize different combinations of washing and density flotation steps. Therefore, the impact of these variations in the proportion of CFSE + vesicles in the final isolate was tested (Fig.   1a ). With the exception of samples ultracentrifuged overnight without a prior density flotation step (UC-II), in which the proportion of vesicular structures was ~70 %, all other ultracentrifugation-derived preparations contained ~85 % of vesicular structures. As in ultracentrifugation-based methods, ExoQuick ® generated samples containing ~80 % of vesicular structures (Fig. 1b) .
The impact of isolation methods in populations of EVs was also tested. For all processing strategies, detectable levels of CFSEevents displaying CD9 expression were found. We firstly assessed whether these events were due to unbound antibody aggregation or CFSE scarcity. Increments in the concentration of CFSE didn't increase the proportion of CFSE + EVs (Fig. S5a) , suggesting that CFSEvesicles are not the result of sub-optimal experimental conditions for CFSE staining. To exclude the potential presence of aggregates of unbound antibodies, a PBS solution containing anti-CD9 antibody in the concentration used in the staining reaction and pre-cleared by SEC was prepared. Increasing acquisition times were captured to generate a calibration curve. For the acquisition times used in the analysis of conditioned medium-derived EVs, less than 8 % of CFSE -CD9 + events could be attributed to unbound anti-CD9 ( Fig.   S5b and c) . The proportion of CFSE + and CFSEparticles within CD9 + particles in samples prepared by different isolation methods was also compared. The number of CFSE -CD9 + particles was reduced after EVs purification by ExoQuick ® or ultracentrifugation ( Figs. 1d and Fig. S5d ), suggesting that the purification methods tested here reduce the presence of CFSE -CD9 + entities.
Quantification of populations of EVs in plasma
The was comparable between samples that had been isolated by UC-I and in native plasma samples (Fig. 2b) . The CFSE -CD9 + population in these two distinct types of plasma samples was also investigated. In non-purified samples, ~50 % of CD9 + events were CFSE -. Notably, this proportion decreased to ~30 % after EVs purification by UC-I ( Figs. 2c and S6b) . Thus, according to our estimate of false-positive events (Fig. S5b) , less than 10% of CD9 + CFSEparticles can be attributed to unbound anti-CD9 antibodies (Fig. S6c) .
Longitudinal population studies of EVs in microvolumes of plasma
We tested the applicability of our FC strategy to longitudinal measurements of populations of EVs in microvolumes of non-purified mouse plasma. The presence of tumor cells is expected to modify the plasmatic levels of EVs during the course of the disease. Therefore, plasma from tumor-bearing mice was collected at different time points. 30 Specifically, blood was collected from each mouse prior to intrahepatic injection of PAN02 pancreatic cancer cells (Day 0), and one (Day 7) and two weeks (Day 14) post-injection, as depicted in Fig. 3a . In this longitudinal analysis of plasma from 10 animals, the proportion of CFSE + events significantly increased in eight of the experimental subjects between days 0-7, in five between days 7-14 and in nine between days 0-14 ( Figs.3b and S7a) . When analyzed in relation to the total concentration of particles present in each time point measured by Nanosight (Fig. 3c) , the concentration of CFSE + events per µL increased in 6 animals between days 0-7 and days 7-14, and in all animals between days 0-14 (Fig. 3d) .
CD9 + populations were measured using the experimental settings already described. The proportion of CD9 + within CFSE + events increased in 8 animals between days 0-7, in 7 animals between days 7-14 and in 9 animals between days 0-14 ( Figs.   3e and S7b) . Similarly, when analyzing this data in relation to the concentration of particles present in plasma (Fig.3c) , an increase of CFSE + CD9 + events per µL in 6 animals between days 0-7 and in 9 animals between days 7-14 and 0-14 ( Fig.3f ) was observed.
Quantification of populations of EVs in vitreous humor
To further illustrate the application of our FC strategy in performing population analysis of EVs in microvolumes of samples, we used it to study EVs in non-purified vitreous humor, of which 2-2.5 μL per mouse/per eye was collected. Approximately 68 % of particles were CFSE + vesicles (Fig. 4a and b) . However, the levels of CD9 + events in vitreous humor (<0 .1% -Fig. 4b) were as low as those found in control PBS containing CFSE and anti-CD9 during equivalent sample running times (Fig. S8 ).
Discussion
Measurement of CFSE + events as a strategy to assess sample purity
The lack of consensus regarding methods for purification of EVs remains a challenge, especially when reproducibility between different isolation modalities is desired. This is further complicated by the insufficient means to measure sample purity, notably in complex samples containing a mixture of vesicular and non-vesicular particles, such as plasma. Multiple strategies, such as measurement of protein:particle ratio 31, 32 and albumin 33, 34 , have been proposed as quality control parameters for the preparation of EVs, particularly when low specificity isolation methods are employed 35 .
However, because they fail to provide population information, it is still unclear whether these metrics can accurately reflect the purity of preparations of EVs.
The data here presented supports the vesicular labeling with CFSE as a means for determining quality control of purification protocols of EVs. As shown, the majority of particles present in samples purified by high-specificity methods were CFSE + . The employment of ExoQuick ® or ultracentrifugation for enrichment of EVs prior to SEC (non-purified) reduced the proportion of CFSEparticles. In addition, lysis of EVs with the detergent NP-40 resulted in a reduction of 90 % of CFSE + events. Together, these results support the usefulness of CFSE as a tool to identify vesicular particles in biofluids, and thus the suitability of our FC strategy for quality control and quantitative comparison of isolates of EVs prepared by different protocols.
This same approach was employed to validate the depletion of EVs from the FBS used in our in vitro studies. Previous reports suggest that traces of bovine EVs may persist in the FBS supernatant after depletion steps, 36 which could interfere in the analysis of EVs from conditioned medium. However, comparison of serum-free medium and medium containing 10 % of EVs-depleted FBS showed an equally reduced proportion of CFSE + events. This indicates that residual FBS-derived EVs was not high enough to impact our analysis. Nonetheless, future studies using our strategy for analysis of EVs in conditioned medium will need to account for background events on a case-by-case basis, especially when using low cell numbers, short conditioning time and/or cells producing low levels of EVs.
Comparison of purification methods of EVs by FC
In spite of being considered to be a high-recovery and low-specificity method, 35 isolation based on precipitation polymers such as ExoQuick ® resulted in a high proportion of CFSE + EVs. This agrees with studies suggesting that EVs prepared by ultracentrifugation or precipitation polymers are comparable. 37, 38 In samples prepared by ExoQuick ® , however, we found that the proportion of CD9 + CFSE + events was reduced when compared to non-purified samples and other isolation methods. This suggests that, despite providing a high yield of EVs, ExoQuick ® may insert EVs population bias. Precipitating agents have previously been linked to potential loss of biological activity 39 and structure 40 of EVs. Thus, our data adds yet another parameter that should be carefully considered before selecting ExoQuick ® as a method of choice for the isolation of EVs.
SEC is the technique of choice for many groups interested in studying the composition and biological activity of vesicles, as it allows simple, fast and affordable isolation of EVs. As SEC is a key component of our FC strategy, the proportion of CFSE + particles in our preparations was measured to access the isolation efficacy of EVs by SEC. Although considered a low recovery, high specificity method 35 , conditioned medium processed by SEC contained less than 40 % of CFSE + vesicular particles. This was also the case for more complex samples, such as plasma and vitreous humor, in which the percentage of CFSE + particles after SEC processing were, respectively, ~20 % and ~68 %. These findings agree with recent studies using comparative transmission electron microscopy, in which SEC-derived preparations displayed a lower proportion of structures resembling EVs when compared to samples derived from differential ultracentrifugation. 41 Differential ultracentrifugation is one of the most commonly used EV purification methods. To improve EV purity, most researchers combine ultracentrifugation with additional techniques following the primary step, such as the use of washing steps with saline and use of density gradients. 42 We found that the proportion of CFSE + events and CD9 + events within the CFSE + gate did not differ in the absence (UC-III) or presence (UC-II and UC-IV) of washing steps with PBS or when a sucrose cushion step was used (UC-I). Our results suggest that these additional steps have no major impact in sample purity. However, a more detailed characterization of the potential impact of these washing and/or separation steps in the selection of populations of EVs with specific composition (protein, sugar, lipid and nucleic acids) will be necessary in future studies.
Together our results show that our FC strategy allows for faster processing times and also substantially decreases the sample volume requirements compared to conventional EVs isolation protocols (Table S2) .
CFSE -CD9 + events
During the course of this work we observed the presence of CFSE -CD9 + particles both in conditioned medium and plasma. Although undesirable, protein aggregation may be present in antibody preparations, mainly due to solution conditions such as ionic strength, pH, temperature, pressure and excipients, 43 and intrinsic properties of antibodies, such as primary sequence, tertiary structure, non-symmetrical hydrophobicity and charge distributions. [44] [45] [46] Therefore, the potential contribution of unbound antibody aggregates to CFSE -CD9 + events was tested. The vast majority of CFSE -CD9 + events did not correspond to unbound antibodies and were substantially reduced by isolation of EVs. Results presented by others indicate that CFSE staining could not label 100 % of EVs. 19, 20, 47 Thus, we reasoned that some of the CFSEevents observed in our experiments could correspond to non-stained EVs. However, unlike the results presented here, in these previous studies CFSE staining was performed in cells before 20 or during medium conditioning, 19 and CFSE concentrations were 1.6 to 16
times lower 19, 20, 47 than those we used. In addition, only ~15 % of the events in samples isolated by differential ultracentrifugation coupled with sucrose cushion (UC-I) were CFSE -, and treatment of EVs with the detergent NP-40 caused a reduction of 90 % of CFSE + events, indicating that this dye labels the majority of EVs in our experimental settings. While this may still suggest that CFSE is not capable of staining all EVs present in the sample, it is still unclear to which extent even high-purity isolation methods may provide 100 % pure preparations of EVs. Although our results suggest that the CFSEevents observed in the CD9 + population may correspond to nonvesicular particles, future studies, including detailed morphology and composition analysis, will be necessary to further interpret these findings.
Longitudinal study of EVs in plasma by FC
Longitudinal composition analyses can provide precious temporal information on the dynamics of EVs in physiological and pathological settings. [48] [49] [50] However, these studies are often difficult in microvolumes of samples, mainly due to the limited number of EVs that can be harvested in these experimental conditions. 35 This constraint frequently leads to insufficient recovery of EVs, 51 unless small volume samples are pooled from multiple individuals or collections. Moreover, in studies involving small animals, the requirement for lethal bleeding in order to collect enough plasma for the effective isolation of EVs complicates the performance of longitudinal studies and increases the demand for animals, leading to higher costs, higher sample processing complexity and potential bioethical issues. By not requiring isolation of EVs prior to staining, our FC strategy allows for the analysis of both intra-and inter-individual heterogeneity in the population of interest throughout an experiment. In our studies, the proportion of CFSE + EVs and of CD9 + events within CFSE + EVs increased in the plasma of mice bearing liver metastatic pancreatic cancer lesions. Based on these results, we are currently studying the potential use of these readouts for follow-up studies of pancreatic cancer patients in the metastatic phase.
Study of EVs in vitreous humor by FC
The vitreous humor is a small-volume biofluid that contains low protein content, ranging from 120 to 500 ng/µL, 52 which is frequently considered to arise from filtration of plasma through fenestrated capillaries of the ciliary body stroma via the iris root. 53 Besides the quantitative differences in protein content, a comparison of vitreous humor and plasma proteome revealed that only 58% of the vitreous humor proteins have also been identified in human plasma. 52 Consistent with this, our analysis revealed that vitreous fluid contains three times more CFSE + vesicular structures when compared to plasma. Furthermore, it contained insignificant levels of CD9 + events, comparable to those found in control solutions with only CFSE and anti-CD9. These results reinforce the idea that the CFSE -CD9 + particles we observed in conditioned medium and plasma are not an artifact, and are consistent with the previously reported absence of CD9 in EVs from vitreous humor. [54] [55] [56] . However, it is still unknown whether the absence of CD9 + vesicles is a result of the filtration that occurs during the production of vitreous humor, uptake and degradation of this vesicle population by ocular cells, higher prevalence of non-endosomal EVs and/or other mechanisms. Although it is unclear to which extend ocular cells contribute to the collection of EVs found in vitreous humor, our FC strategy can be potentially used to study these vesicles both in pre-clinical and clinical settings as potential biomarkers and biological mediators of eye diseases.
Conclusion
By allowing for the analysis of conditioned medium volumes as small as 100 µL, our FC strategy can be potentially used to characterize the heterogeneity of EVs and the differential packaging of biomolecules during the biogenesis of EVs in highly 
Figure Legends
